Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Top highlights include: Hospitals in less competitive regions have higher price transparency compliance, study finds, Many won’t rely on virtual options after COVID: AP-NORC poll, Exercise can cut all sorts of health risks for seniors. Here’s how to get going.
Mayo Clinic is the first and only PCD Foundation accredited center for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease.
In June 2022, Mayo Clinic Laboratories announced forty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
As manager of the department’s Education Program, Deb Hagen-Moe and her team welcome new staff to Mayo Clinic’s Department of Laboratory Medicine and Pathology. Then they continue to offer a wide range of continuing education and professional development to those staff members throughout their careers.
This week’s research roundup features: The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses.
This list includes updates posted to mayocliniclabs.com during the month of June.
Top highlights include: CMS rolls out new payment model on improving cancer treatments, Mayo Clinic Waseca breaks ground on renovation project, Wearables are collecting a flood of data - an ambitious new study of pregnancy aims to prove that's valuable for health.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Darci Block, Ph.D., assistant professor of Laboratory Medicine and Pathology and consultant in Clinical Core Laboratory Services at Mayo Clinic, to discuss challenges of saliva testing.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the recent Department of Health and Human Services announcement that named Mayo Clinic Laboratories as one of five commercial labs to expand capacity for monkeypox testing. They also discuss newly introduced legislation – the Saving Access to Laboratory Services Act (SALSA).
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.
This week’s research roundup features: Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.
Partnering with Mayo Clinic has helped St. Clair Health improve patient care and gain a new competitive advantage in pharmacogenetics.